Position in HLN
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$761,449
-$55,497 QoQ
Shares Held
81,613
0.0% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#159
of 639 holders
Holding Since
Sep 2022
16 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in HLN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Cohen Klingenstein LLC holds $1,371,249 across 3 Drug Manufacturers - Specialty & Generic names. HLN ranks #1 (55.5% of the industry book) .
All Filings in HLN
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $761,449 | 81,613 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $816,946 | 81,613 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $825,107 | 81,613 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $732,068 | 81,613 | Shares | Sole | 2025-10-16 | |
| 2025-06-30 | $846,326 | 81,613 | Shares | Sole | 2025-07-18 | |
| 2025-03-31 | $839,797 | 81,613 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $778,588 | 81,613 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $944,339 | 89,257 | Shares | Sole | 2024-10-16 | |
| 2024-06-30 | $745,811 | 90,292 | Shares | Sole | 2024-07-15 | |
| 2024-03-31 | $1,019,156 | 120,042 | Shares | Sole | 2024-04-12 | |
| 2023-12-31 | $1,251,305 | 152,042 | Shares | Sole | 2024-01-16 | |
| 2023-09-30 | $1,403,538 | 168,492 | Shares | Sole | 2023-10-13 | |
| 2023-06-30 | $1,425,739 | 170,136 | Shares | Sole | 2023-07-14 | |
| 2023-03-31 | $1,384,907 | 170,136 | Shares | Sole | 2023-04-14 | |
| 2022-12-31 | $1,361,088 | 170,136 | Shares | Sole | 2023-01-13 | |
| 2022-09-30 | $1,288,035 | 211,500 | Shares | Sole | 2022-10-12 | |
| No filing history on record for this holder in this stock. | ||||||